Sustained Chorea Improvements with Long-term, Once-daily Valbenazine in Adults with Huntington’s Disease (S37.009)
To present results from KINECT®-HD2 (NCT04400331), an open-label study of once-daily valbenazine for chorea in adults with Huntington’s disease (HD).
Authors
- Eduardo Dunayevich
- Raja Mehanna (ORCID: https://orcid.org/0000-0003-1704-3683)
- Grace Liang (ORCID: https://orcid.org/0009-0008-2581-4891)
- Dietrich Haubenberger (ORCID: https://orcid.org/0000-0002-6233-8168)
- Olga Klepitskaya
- Daniel O. Claassen (ORCID: https://orcid.org/0000-0002-9853-4902)
- Jody Goldstein
- Sean C. Hinton
- Elise Kayson
- Hui Zhang
- Shree Karpuram
- Erin Furr Stimming
Institutions
- Neurocrine Biosciences (United States) (US)
- Vanderbilt University Medical Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000211985
- Primary Topic
- Genetic Neurodegenerative Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00